Imatinib mesylate presents a cytostatic effect on B16 cells in vitro and an apoptotic outcome in melanoma in vivo

Research output: Contribution to conference › Abstract › peer-review

Original language	English
DOIs	https://doi.org/10.1096/fasebj.23.1_supplement.625.14
Publication status	Published - Apr 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@conference{1f9d416497584b708271604e37b11bfe,

title = "Imatinib mesylate presents a cytostatic effect on B16 cells in vitro and an apoptotic outcome in melanoma in vivo",

author = "Ana Pirraco and Pedro Coelho and Ana Rocha and Raquel Costa and Raquel Soares",

year = "2009",

month = apr,

doi = "10.1096/fasebj.23.1\_supplement.625.14",

language = "English",

}